Vol 5, No 4 (2019)
Case report
Published online: 2020-02-05
Zapalenie skórno-mięśniowe oporne na steroidy skutecznie leczone dożylnym preparatem immunoglobulin
DOI: 10.5603/FR.2019.0023
Forum Reumatol 2019;5(4):209-213.
Abstract
W pracy przedstawiono przypadek 58-letniej kobiety z zapaleniem skórno-mięśniowym, u której pomimo zastosowania standardowego leczenia glikokortykosteroidami nie osiągnięto poprawy klinicznej. Wprowadzenie do terapii preparatu immunoglobulin doprowadziło do znacznego zwiększenia siły mięśniowej, ustąpienia zmian skórnych i normalizacji parametrów laboratoryjnych.
Forum Reumatol. 2019, tom 5, nr 4: 209–213
Keywords: zapalenie skórno-mięśniowemiopatia zapalnaimmunoglobuliny
References
- Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975; 292(7): 344–347.
- Lundberg IE, Tjärnlund A, Bottai M, et al. International Myositis Classification Criteria Project consortium, The Euromyositis register and The Juvenile Dermatomyositis Cohort Biomarker Study and Repository (JDRG) (UK and Ireland). 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis. 2017; 76(12): 1955–1964.
- Cafardi JM, Sami N. Intravenous Immune Globulin in Amyopathic Dermatomyositis - Report of Two Cases and Review of the Literature. Open Rheumatol J. 2015; 9: 77–81.
- Okogbaa J, Batiste L. Dermatomyositis: An Acute Flare and Current Treatments. Clin Med Insights Case Rep. 2019; 12: 1179547619855370.
- Świerkot J, Lewandowicz-Uszyńska A, Bogunia-Kubik K. Paraneoplastic syndromes and rheumatic diseases. Postępy Higieny i Medycyny Doświadczalnej. 2014; 68: 944–954.
- Oddis CV. Update on the pharmacological treatment of adult myositis. J Intern Med. 2016; 280(1): 63–74.
- Dalakas MC, Illa I, Dambrosia JM, et al. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med. 1993; 329(27): 1993–2000.
- Miyasaka N, Hara M, Koike T, et al. GB-0998 Study Group. Effects of intravenous immunoglobulin therapy in Japanese patients with polymyositis and dermatomyositis resistant to corticosteroids: a randomized double-blind placebo-controlled trial. Mod Rheumatol. 2012; 22(3): 382–393.
- Cherin P, Pelletier S, Teixeira A, et al. Results and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty-five adult patients. Arthritis Rheum. 2002; 46(2): 467–474.
- Saito E, Koike T, Hashimoto H, et al. Efficacy of high-dose intravenous immunoglobulin therapy in Japanese patients with steroid-resistant polymyositis and dermatomyositis. Mod Rheumatol. 2008; 18(1): 34–44.
- Femia AN, Vleugels RA, Callen JP. Cutaneous dermatomyositis: an updated review of treatment options and internal associations. Am J Clin Dermatol. 2013; 14(4): 291–313.
- Bakewell CJ, Raghu G. Polymyositis associated with severe interstitial lung disease: remission after three doses of IV immunoglobulin. Chest. 2011; 139(2): 441–443.
- Marie I, Menard JF, Hatron PY, et al. Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients. Arthritis Care Res (Hoboken). 2010; 62(12): 1748–1755.
